Preoperative PET or PET/CT for malignant diagnosis of Gastrointestinal stromal tumors: a systematic review and meta-analysis
Preoperative PET or PET/CT exhibited excellent diagnostic performance in predicting malignancy in GISTs
Preoperative PET or PET/CT exhibited excellent diagnostic performance in predicting malignancy in GISTs and may be employed as an effective non‑invasive imaging device for guiding preoperative preparation when biopsy is not possible and prognostic analysis for patients with localized primary GISTs who underwent radical surgery.
The study demonstrates that PET or PET/CT can non‑invasively pre‑operatively determine malignant potential of GISTs, which can guide surgical planning and prognostication in a disease where biopsy may be limited.
Evidence level: Feltételezés / hírjelzés. Nincs önálló tudományos bizonyíték.
Related signals
- Disproportionality analysis of adverse events associated with tyrosine kinase inhibitors in gastrointestinal stromal tumors in the FDA adverse event reporting system
- Review of Genomic Testing and SDH Deficiency in Gastrointestinal Stromal Tumors: Getting to the GIST
- Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives
- Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach
- UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST)